Highlights Hubei Huarong Holding Co.,Ltd.

Equities

600421

CNE000001HY9

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
6.33 ^CNY	-2.16%		+3.77%	-43.13%

Apr. 24	Hubei Huarong Holding Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
2023	Hubei Huarong Holding Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Hubei Huarong Holding Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 24	CI
Hubei Huarong Holding Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-18	CI
Hubei Huarong Holding Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-29	CI
Huarong Holding to Buy Local Optical Device Maker, Marking Foray Into Sensor Industry; Shares Jump 3%	23-06-20	MT
Hubei Huarong Holding Co.,Ltd. agreed to acquire Nanjing Kaituo Optoelectronics Technology Co., Ltd. from a group of sellers	23-06-16	CI
Hubei Huarong Holding Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
Hubei Huarong Holding Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-18	CI
Hubei Huarong Holding Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-25	CI
Hubei Huarong Holding Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-24	CI
Hubei Huarong Holding Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-27	CI
Hubei Huarong Holding Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-30	CI
Hubei Huarong Holding Co.,Ltd. signed the Reorganization Intention Agreement to acquire Shanghai Outdo Biotech Co., Ltd. from Shanghai Biochip Co., Ltd., Yinzhou City Construction Investment Devp Co,.Ltd, Tianjin Zhike Biotechnology Partnership (Limited Partnership) and Shanghai Qianxin Enterprise.	21-12-28	CI
Hubei Huarong Holding Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-27	CI
Hubei Huarong Holding Co.,Ltd. cancelled the acquisition of 80% stake in Wuxi Shenrui Bio-Pharmaceuticals Products Co., Ltd. from Sheng Qingsong, Tan Qingzhong, CDH Investment Management Company Limited, Wuxi Shenrui Investment Partnership, Shanghai CDH Chuangtai Venture Capital Center, Wuxi Ruiyi Enterprise Management Consulting Partnership and Wuxi Ruiyu Enterprise Management Consulting Partnership.	21-09-02	CI
Hubei Huarong Holding Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-27	CI
Hubei Huarong Holding Co.,Ltd. entered into an agreement to acquire 80% stake in Wuxi Shenrui Bio-Pharmaceuticals Products Co., Ltd. from Sheng Qingsong, Tan Qingzhong, CDH Investment Management Company Limited, Wuxi Shenrui Investment Partnership, Shanghai CDH Chuangtai Venture Capital Center, Wuxi Ruiyi Enterprise Management Consulting Partnership and Wuxi Ruiyu Enterprise Management Consulting Partnership.	21-07-16	CI
Hubei Huarong Plans to Buy 80% Stake in Biological Product Firm	21-07-16	CI
Hubei Huarong Plans to Buy Bio Pharmaceuticals Firm	21-07-04	CI
Hubei Huarong Holding Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-27	CI
Hubei Huarong Holding Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-27	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Hubei Huarong Holding Co.,Ltd.

Equities

600421

CNE000001HY9

Highlights

Filters